103 related articles for article (PubMed ID: 15475446)
1. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
[TBL] [Abstract][Full Text] [Related]
2. CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients-Diamond Study).
Russo GI; Durukan E; Asmundo MG; Lo Giudice A; Salzano S; Cimino S; Rescifina A; Fode M; Abdelhameed AS; Caltabiano R; Broggi G
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731981
[TBL] [Abstract][Full Text] [Related]
3. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract][Full Text] [Related]
4. PTEN regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller K; Degan S; Wang Y; Cohen J; Ku SY; Goodrich D; Gelman I
Res Sq; 2023 May; ():. PubMed ID: 37292818
[No Abstract] [Full Text] [Related]
5. Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications.
Singh N; Heemers HV
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279256
[TBL] [Abstract][Full Text] [Related]
6. Significance and expression of p-Akt in oral squamous cell carcinoma.
Hindy SA
J Oral Maxillofac Pathol; 2022; 26(4):602. PubMed ID: 37082060
[TBL] [Abstract][Full Text] [Related]
7. Targeting PI3K/Akt signaling in prostate cancer therapy.
Hashemi M; Taheriazam A; Daneii P; Hassanpour A; Kakavand A; Rezaei S; Hejazi ES; Aboutalebi M; Gholamrezaie H; Saebfar H; Salimimoghadam S; Mirzaei S; Entezari M; Samarghandian S
J Cell Commun Signal; 2023 Sep; 17(3):423-443. PubMed ID: 36367667
[TBL] [Abstract][Full Text] [Related]
8. The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer.
Shen D; Peng H; Xia C; Deng Z; Tong X; Wang G; Qian K
Front Mol Biosci; 2022; 9():939070. PubMed ID: 35923466
[TBL] [Abstract][Full Text] [Related]
9. SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z
Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248
[TBL] [Abstract][Full Text] [Related]
10. Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc.
Lin CY; Wang BJ; Chen BC; Tseng JC; Jiang SS; Tsai KK; Shen YY; Yuh CH; Sie ZL; Wang WC; Kung HJ; Chuu CP
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766290
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.
Koshkin VS; Mir MC; Barata P; Gul A; Gupta R; Stephenson AJ; Kaouk J; Berglund R; Magi-Galluzzi C; Klein EA; Dreicer R; Garcia JA
Invest New Drugs; 2019 Jun; 37(3):559-566. PubMed ID: 31037562
[TBL] [Abstract][Full Text] [Related]
12. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer.
Xiong X; Schober M; Tassone E; Khodadadi-Jamayran A; Sastre-Perona A; Zhou H; Tsirigos A; Shen S; Chang M; Melamed J; Ossowski L; Wilson EL
Cell Rep; 2018 Dec; 25(11):3006-3020.e7. PubMed ID: 30540935
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancer.
Xu J; Lan Y; Yu F; Zhu S; Ran J; Zhu J; Zhang H; Li L; Cheng S; Xiao Y; Li X
Oncotarget; 2018 May; 9(38):24936-24949. PubMed ID: 29861844
[TBL] [Abstract][Full Text] [Related]
14. Profiling Prostate Cancer Therapeutic Resistance.
Wade CA; Kyprianou N
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562686
[TBL] [Abstract][Full Text] [Related]
15. Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer.
Jiang D; Xiao C; Xian T; Wang L; Mao Y; Zhang J; Pang J
Onco Targets Ther; 2018; 11():1077-1086. PubMed ID: 29535532
[TBL] [Abstract][Full Text] [Related]
16. A nomogram based on phosphorylated AKT1 for predicting locoregional recurrence in patients with oesophageal squamous cell carcinoma.
Yu W; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
J Cancer; 2017; 8(18):3755-3763. PubMed ID: 29151963
[No Abstract] [Full Text] [Related]
17. The regulation of snail: on the ubiquitin edge.
Yu Q; Zhou BP; Wu Y
Cancer Cell Microenviron; 2017; 4(2):. PubMed ID: 29147673
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise.
Sumanasuriya S; De Bono J
Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 29101113
[TBL] [Abstract][Full Text] [Related]
19. AKT can modulate the
Silva-Oliveira RJ; Melendez M; Martinho O; Zanon MF; de Souza Viana L; Carvalho AL; Reis RM
Oncotarget; 2017 Aug; 8(32):53288-53301. PubMed ID: 28881811
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific interaction between glutathione peroxidase 1 and manganese superoxide dismutase affects the levels of Bcl-2, Sirt3 and E-cadherin.
Ekoue DN; Bera S; Ansong E; Hart PC; Zaichick S; Domann FE; Bonini MG; Diamond AM
Free Radic Res; 2017 Jun; 51(6):582-590. PubMed ID: 28587495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
